Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ros Glasspool
Phase 2 Multicentre Trial Investigating Intermittent and Continuous Dosing Schedules of the Poly(ADP-Ribose) Polymerase Inhibitor Rucaparib in Germline BRCA Mutation Carriers With Advanced Ovarian and Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
Related publications
The Inhibition and Treatment of Breast Cancer With Poly (ADP-ribose) Polymerase (PARP-1) Inhibitors
International Journal of Biological Sciences
Applied Microbiology
Evolution
Ecology
Developmental Biology
Cell Biology
Molecular Biology
Systematics
Behavior
Biotechnology
Phase 1 Trial of Olaparib and Oral Cyclophosphamide in BRCA Breast Cancer, Recurrent BRCA Ovarian Cancer, Non-Brca Triple-Negative Breast Cancer, and Non-Brca Ovarian Cancer
British Journal of Cancer
Cancer Research
Oncology
Global Analysis of Transcriptional Regulation by Poly(ADP-Ribose) Polymerase-1 and Poly(ADP-Ribose) Glycohydrolase in McF-7 Human Breast Cancer Cells
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Treatment of Breast Cancer 2 (BRCA2)-mutant Follicular Dendritic Cell Sarcoma With a Poly ADP-ribose Polymerase (PARP) Inhibitor: A Case Report
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
Proteomic Investigation of Phosphorylation Sites in Poly(ADP-Ribose) Polymerase-1 and Poly(ADP-Ribose) Glycohydrolase
Journal of Proteome Research
Biochemistry
Chemistry
Poly (ADP-ribose) Polymerase Inhibitor, an Effective Radiosensitizer in Lung and Pancreatic Cancers
Oncotarget
Oncology
Targeting Poly(ADP-Ribose) Polymerase Activity for Cancer Therapy
Cellular and Molecular Life Sciences
Molecular Neuroscience
Molecular Medicine
Cell Biology
Molecular Biology
Pharmacology
Cellular
Poly(ADP-Ribose) Polymerase-1 mRNA Expression in Human Breast Cancer: A Meta-Analysis
Breast Cancer Research and Treatment
Cancer Research
Oncology
Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic Syndromes
Cancers
Cancer Research
Oncology